Gamma glutamyl cysteine ligase (GCL) is the rate-limiting enzyme for intracellular glutathione (GSH) synthesis. The GSH concentration and GCL activity are declining with age in the central nervous system (CNS), and is accompanied by elevated reactive oxygen species (ROS). To study the biological effects of low GSH levels, we disrupted its synthesis both at birth by breeding a Gclc loxP mouse with a thy1-cre mouse (NEGSKO mouse) and at a later age by breeding with a CaMKII-ERT2-Cre (FIGSKO mouse). NEGSKO mice with deficiency of the Gclc in their entire CNS neuronal cells develop at 4 weeks: progressive motor neuron loss, gait problems, muscle denervation and atrophy, paralysis, and have diminished life expectancy. The observed neurodegeneration in Gclc deficiency is of more chronic rather than acute nature as demonstrated by Gclc targeted singleneuron labeling from the inducible Cre-mediated knockout (SLICK) mice. FIGSKO mice with inducible Gclc deficiency in the forebrain at 23 weeks after tamoxifen induction demonstrate profound brain atrophy, elevated astrogliosis and neurodegeneration, particularly in the hippocampus region. FIGSKO mice also develop cognitive abnormalities, i.e. learning impairment and nesting behaviors based on passive avoidance, T-Maze, and nesting behavior tests. Mechanistic studies show that impaired mitochondrial glutathione homeostasis and subsequent mitochondrial dysfunction are responsible for neuronal cell loss. This was confirmed by mitochondrial electron transporter chain activity analysis and transmission electron microscopy that demonstrate remarkable impairment of state 3 respiratory activity, impaired complex IV function, and mitochondrial swollen morphology in the hippocampus and cerebral cortex. These mouse genetic tools of oxidative stress open new insights into potential pharmacological control of apoptotic signaling pathways triggered by mitochondrial dysfunction.
Introduction
The mammalian brain is said to be much more sensitive to oxidative stress compared to the other organs (1) mainly due to its high O 2 consumption, enriched PUFA in neuronal membrane and high Ca 2þ traffic. Evidence from a number of studies suggests that oxidative stress is a final common pathway in various forms of neuronal cell death, including a wide variety of acute and chronic neurological diseases, as well as in normal aging (1) (2) (3) . Mitochondria have been considered the major source of ROS, and their dysfunction with time appears to contribute to neurodegeneration and aging (4, 5) . Indeed, mitochondrial dysfunction has been identified in several neurodegenerative disorders (6) (7) (8) . In addition, mitochondria are not only an important source of ROS in aerobic cells, but they are also sensitive targets for the damaging effects of oxygen radicals (9) . For instance, damage to mitochondrial DNA (mtDNA), which is especially susceptible to attack by ROS, can not only compromise energy production but can also result in enhanced ROS generation through the loss of functional respiratory complexes (10) . Glutathione (GSH), which is present at millimolar concentration, is considered to be the most prevalent and important intracellular non-protein thiol/sulfhydryl compound in mammalian cells. It is involved in multiple roles, such as antioxidant defense, detoxification of xenobiotics, intracellular redox homeostasis, cysteine carrier and storage, cell signaling, protein function, gene expression, and cell differentiation and proliferation (11) (12) (13) . GSH level has been reported to decline in the aging brain (9, 14) , as well as in the brain of many neurodegenerative diseases, i.e. Parkinson disease (PD) (15), Alzheimer's disease (10) , and amyotrophic lateral sclerosis (ALS) (16) . However, rather surprisingly and importantly, mice in which the c-glutamate cysteine ligase, modifier subunit (Gclm) was knocked out had as much as 70% depletion of brain GSH (17) and manifested with only mild abnormalities in neurons (17) , such as reduced synchronous network activity in the ventral hippocampus, while other studies demonstrated no clear phenotype and behavior changes (18) . On the other hand, neurodegeneration occurred when GSH de novo synthesis was blocked with buthionine sulfoximine (BSO) in newborn mice and rats (19, 20) , and also when the c-glutamate cysteine ligase, catalytic subunit (Gclc) was targeted in dopaminergic neurons by antisense (21) or virus-based RNAi (22) . Indeed Gclc activity was found to be decreased in older brains and neurodegenerative disease (23) . Furthermore, some case-control studies have found the association of various diseases with Gclc polymorphisms, i.e. stroke (24, 25) , lung function loss (26) and risk of renal disease in type I diabetes (27) . Mice with hepatocyte-specific Gclc deletion develop liver failure (28) .
In order to clarify the above discrepancy, we investigated in the present study the neurodegenerative process triggered by Gclc deficiency at various stages and regions in the central nervous system (CNS) using congenital and induced conditional Gclc knockout mouse models, focusing in particular on the role of mitochondrial dysfunction in neurodegeneration.
Results

The CNS Gclc deficiency results in GSH depletion and triggers neuronal cell loss
To investigate this paradigm without embryonic lethality from systematic Gclc knockout (29) , we created a conditional Gclc knockout mouse by breeding our home made loxP floxed Gclc mice (30) with the Thy1-Cre transgenic mice, and named it Neuronal GSH Knockout (NEGSKO) mouse. Cre recombinase under Thy1 promoter is pan-neuronal, while only postnatally expressed in neurons of the central nervous system (CNS) as described by others (31) . At birth, homozygous NEGSKO mice were morphologically and behaviorally indistinguishable from control littermates (wild type, Gclc fl/fl or Thy1-cre
). NEGSKO mice developed a gait abnormality by approximately $22 days of age, had a slightly reduced body size, and had a postnatal life expectancy of approximately 4-5 weeks (Fig. 1A) . 4 weeks old NEGSKO mice showed an abnormal clasping reflex during the tailing hanging test (Fig. 1B) , and a disturbed footprint pattern and markedly wide-based stance, small stride, and frequent offline stumbling pattern compared to the wild type mice (Fig. 1C) . GSH level was reduced over 50% in the spinal cord, hippocampus, cortex, and cerebellum, with around two fold elevation of the GSSG/GSH ratio, an index of reactive oxygen species (ROS) formation ( Fig. 1D and E, Supplementary Material, Table S1 ). As expected, the CNS Gclc deletion did not affect GSH and GSSG levels in plasma (Fig. 1D) . To further clarify whether impaired GSH biosynthesis could affect the level of glutathionylation, a protein bound glutathione that is also playing an important role in GSH homeostasis, we determined the protein-bound glutathione by immunoblot using anti-glutathione antibody. As illustrated in Supplementary Material, Figure S1 , there was no noticeable change between wild type and NEGSKO mice in hippocampus and spinal cord tissues.
Histopathological examination revealed significant motor neuron atrophy in the spinal cord from the lobar sections (L3 to L5) at postnatal day 28 in NEGSKO vs. wild type mice ( Fig. 1H  and I ), but not at postnatal day 9 ( Fig. 1F and G) . The motor neuron specific marker Islet-1 immunofluorescence stain ( Fig. 1J and K) and cell counts (Fig. 1L ) at postnatal day 28 confirmed the neuronal cell loss compared to WT mice. NEGSKO mice also displayed moderate shrinkage in the brain cortex, while normal morphology of hippocampus and dentate gyrus was preserved at postnatal day 28 (Supplementary Material, Fig. S2 ). Further analysis indicated neuronal apoptosis by TUNEL stain in the spinal cord of NEGSKO mice ( Fig. 2A-F ). Significant elevation of cleaved caspase 3 in the brain and spinal cord (Supplementary Material, Fig. S3 ), together with increased translocation of cytochrome C into the cytoplasm (Fig. 2G ) implicated intrinsic apoptosis via a mitochondrial dependent pathway was involved in neurodegeneration.
The observation that NEGSKO mice manifested with gait problems and motor neuron degeneration inspired us to explore its impact on muscle functions. Scattered and grouped muscle fiber atrophy was found in the gastrocnemius ( Fig. 2H and I ). Coherent with muscle atrophy, neuromuscular junctions (NMJ) stained with neurofilament, synaptophysin and Alexa Fluor-488 conjugated a-bungarotoxin (a-BGT) revealed structural changes such as terminal axonal dystrophy and convergence of two or more axons on a single postsynaptic site clearly indicative of muscle denervation (Supplementary Material, Fig. S4 ). Additional proof of muscular denervation was brought by electromyography (EMG). As illustrated in Figure 2L , an electromyogram done in the gastrocnemius muscle at postnatal day 28 NEGSKO mice showed numerous fibrillation potentials indicative of loss of muscle fiber innervation, and fasciculations, which represent spontaneous firing of motor units commonly seen in human motor neuron diseases. We did not see muscle atrophy and denervation at postnatal day 9 in NEGSKO mice, suggesting that the gait problem and death observed in NEGSKO mice originated from neurodegeneration caused by Gclc deletion. Interestingly, significant loss (>50%) of cholinergic neurons in the spinal cord, especially the posterior column, was demonstrated with a choline acetyltransferase (ChAT) stain (Fig. 2J-L) , implying a mechanistic link between acetylcholine and Gclc deletion.
Consistent findings in Gclc targeted single-neuron labeling from inducible Cre-mediated knockout mouse Next, we aimed to clarify two questions, 1) whether the above observed neurodegeneration was merely a consequence of development, even though we did not see clear phenotypical differences between NEGSKO and WT mice at postnatal day nine.
2) Whether the neuronal cells die spontaneously after Gclc deletion if there is no GSH present intracellularly, even though we found this was not the case in the mouse lens Gclc knockout study (32) . To address these concerns, we created a mouse, in which Gclc was deleted under single-neuron labeling with inducible Cre-mediated knockout (SLICK) as reported (33) . This was achieved by coexpressing a Tamoxifen (TM) inducible Cre recombinase and a fluorescent protein also under Thy1 promoter. This allowed us to image the morphology of neurons with the fluorescent labeling in single neurons without phenotypic changes due to extremely low Cre expression levels. At six months of age, Gclc deletion was induced by TM injection in the Gclc-SLICK mice, and the neuronal cell morphology was monitored at 6 and 22 weeks after TM induction, respectively. Based on the confocal z-scan image, 2 weeks after TM injection, there were a significant number of neurons showing green fluorescence ( Fig. 3A and C) , which indicated that these neurons were having successful Cre expression and Gclc gene deletion (33) . The significant motor neuron loss was discovered at 22 weeks after TM induction ( Fig. 3B and C) , but around 35% of neurons are still survived. These results indicate that the neurons with Gclc deletion did not die spontaneously, and the neurodegeneration was triggered by a Gclc deletion in a timely manner, and that gait abnormality in the NEGSKO mice was unlikely to be caused by a developmental defect. Similarly, gastrocnemius muscle showed intact morphology 2 weeks after TM induction and the significant loss of muscular neurons, pre-synaptic nerve terminals, and the juxtaposition with postsynaptic AChR clusters was discovered at week 22 post-TM induction ( Fig. 3D-I ).
The forebrain inducible Gclc deletion leads to neurodegeneration
We now know that Gclc deletion will trigger the chronic neuronal cell degeneration. Next, we like to confirm whether this is the case if we selectively delete Gclc in CNS. By breeding our LoxP floxed Gclc mice with CamKII-cre/Ert2 mouse (34), we created an inducible forebrain Gclc knockout for phenotypic study, named as forebrain inducible neuronal GSH Knockout Mouse (FIGSKO). At 3 months old, mice were induced by TM injection for Cre expression and Gclc deletion. The Lox-Cre mice without TM injection served as control in the entire FIGSKO mice studies. Food intake, body weight, and mortality were monitored on a weekly basis. We did not see major differences in food intake and body weight ( Fig.  4C ) between the FIGSKO and control mice for up to 25 weeks after TM induction, but thereafter the FIGSKO mouse body weight dropped remarkably and was associated with significant mortality (Fig. 4D ). We performed most assays at 23 weeks post-TM injection, i.e. significantly before the drop in body weight. At 23 weeks after TM injection, the FIGSKO mice demonstrated brain atrophy compared to the control both in terms of size and the relative ratio of brain to body weight ( Fig. 4A and B) . FIGSKO mice demonstrated remarkable neurodegeneration in hippocampus 23 weeks after TM induction based on the results of the H&E stain ( Fig. 4E-H) and $80% neuronal cell loss based on neuronal cell counts after Nissl stain ( Fig. 4I ) while relatively good morphology was maintained in the gyrus ( Fig. 4E-H ). In the same region, the glial fibrillary acidic protein (GFAP) stain indicated high levels of astrogliosis as shown in Supplementary Material, Figure S5 .
Intriguingly, we noticed the FIGSKO mice slowly decreased nesting behavior as shown in Figure 5A -C and quantitatively in Figure 5D . At 23 weeks after TM induction, we also performed other behavior tests. The Passive Avoidance test is a fearaggravated test used to evaluate learning and memory in rodent models of CNS disorders. In this test, subjects learn to avoid an environment in which an aversive foot-shock was previously delivered. As illustrated in Figure 5E , two combined post-training tests showed remarkable impairment in FIGSKO mice in terms of learning and memorization of the foot-shock delivered before. We also performed the T-Maze test, a device measuring animal exploratory behavior. As illustrated in Figure 5F , starting from training session 6, FIGSKO mice demonstrated significantly lower alteration compared to age-matched control mice. These results clearly indicated that Gclc deletion in the forebrain triggered neurodegeneration and impaired cognitive functions.
Gclc deficiency affects mitochondrial GSH homeostasis and induces mitochondrial dysfunction
Finally, we sought to shed light on the mechanism of Gclc deficiency on neurodegeneration. As illustrated in Figure 6a , both brain and spinal cord mitochondrial GSH levels were reduced over 40% in the NEGSKO mice compared to wild type mice, while cytoplasmic levels were reduced up to 50-70%. This led us to investigate mitochondria as a possible mechanism of neurodegeneration triggered by Gclc deficiency. The further determination of brain mitochondrial function indicated mitochondrial damage in NEGSKO mice. State 3 oxidation rates of glutamate þ malate and pyruvate þ malate were lower in knockout brain mitochondria compared to the control (Fig. 6B) . Since the oxidation of both substrates generates NADH, which donates the reducing equivalents to complex I in the electron transport chain (ETC), the data suggest that the ETC rather than the formation of NADH from these substrates is affected by the knockout state. The oxidation of succinate, which donates electrons to FAD in complex II, also was decreased by the knockout state, as were the state 3 respiratory rates with durohydroquinone (complex III electron donor) and those with the cytochrome c-complex IV donor TMPD þ Ascorbate (Fig. 6C) . The uncoupler disconnects the oxidation and phosphorylation sides of the oxidative phosphorylation (OXPHOS), and increases the oxygen consumption to maximal rates if the OXPHOS is limited by the components of the phosphorylation apparatus (phosphate transporter, adenine nucleotide translocase, ATP synthase). The uncoupled rates with all substrates also were lower in the knockout mitochondria (Fig. 6C) , indicating that the OXPHOS is deficient at the oxidation arm. This arm was dissected in uncoupled conditions by using substrates that donate electrons at specific sites in the ETC. Because the oxidation of complex I, II and III substrates depends on the integrity of complex IV, the data suggested that the decrease in OXPHOS is due to a defect in cytochrome c or complex IV. The specific activities of complex I, II and III are not changed in brain mitochondria isolated from the knockout mice, whereas the activity of complex IV is decreased (Fig. 6D) indicating that cytochrome c oxidase is a specific target of the knockout state. Mitochondrial dysfunction results in reduced production of ATP and decreased ATP/ADT ratio in both brain and spinal cord ( Fig. 6E and F) . Mitochondrial alterations are likely induced by GSH depletion.
Similar results were also found in the FIGSKO mouse, 23 weeks after TM induction, the mitochondrial GSH level is significantly reduced in cerebral cortex mitochondria, but not in the cerebellum (Fig. 7A) , similar levels of GSH were also seen at 7 weeks in FIGSKO mice after TM induction and the ATP production in both the cerebral cortex and the hippocampus were significantly reduced in FIGSKO mice 23 weeks after TM induction (Supplementary Material, Fig. S6 ), as well as mitochondrial membrane potential measured from isolated neuronal cell culture using rhodamine 123 labeling approach (Fig. 7B) . Ultrastructure analysis using transmission electron microscopy (TME) showed a remarkable degree of mitochondrial-swollen in FIGSKO mice 23 weeks after TM induction compared to control mice in both the cerebral cortex and hippocampus region as illustrated in Figure 7C -F. These results from both NEGSKO and FIGSKO mice clearly indicated mitochondrial dysfunction was the most common mechanism responsible for neurodegeneration in Gclc deficiency mice.
Discussion
This study, using three types of conditional knockout mouse models, targeting Gclc deletion at various stages, in different CNS regions, demonstrates the critical role of the key GSH biosynthesis enzyme, Gclc, in neuronal cells' survival. The profound phenotype from Gclc deficiency mouse draws a sharp contrast to the Gclm knockout mouse, even though both models have reached similar CNS GSH depletion (17) . Two possible mechanisms may explain the different phenotypical outcome between the Gclc and Gclm knockout mouse. The Gclm mouse is a systemic knockout mouse, and over 70% GSH depletion is contributed by both neuronal and supporting cells, while, the Gclc conditional knockout in this study specifically targets neuronal cells. One possibility is that the neuronal cells in the Gclm mouse may have relative high levels of GSH content, thus no neurodegeneration occurs. To specifically measure neuronal cells GSH level in vivo is a challenging task. The fluorescence-based probe, such as ThiolTracker violet (35) and ThiolQuant green (36) have been demonstrated as a very sensitive GSH indicators in cell culture system. However, whether it can be utilized for in vivo tissue GSH quantification remains to be fully clarified. Nevertheless, the chronic neurodegeneration in Gclc deficient mice suggesting neuronal cells are managing to maintain substantial levels of GSH. Furthermore, numerous studies (37, 38) indicate the neuronal protective role of astrocytes in part due to a continuous supply of GSH to surrounding neuronal cells. It has been found that GSH concentrations in astrocytes appears to be higher than in neurons (39) , and similar results are also reported in in vitro cultured microglial cells (40, 41) . In addition, we have also found that mouse lenses still maintain around 2 mM (50%) of GSH despite complete absence of lens GSH biosynthesis by Gclc deletion (30) . These results suggest a compensatory mechanisms help cells maintain minimum intracellular GSH levels, i.e. via transport extracellular GSH. Limited research also supports the existence of a GSH transporter system in the CNS, in Cell counts based on Nissl stain. 5 mice in each group were used for (A) and (B), 20 mice in each group were used for (C) and (D), 10 mice in each group were used for (E-I). Student's t-test was used to compare FIGSKO and control mice. Only P values <0.05 were considered statistically significant. particular brain endothelial cells and astrocytes (42) . In that regard, we expect that the Gclc KO mice shall provide a useful platform for GSH transporter(s) studies in CNS. Apparently, precisely measuring the GSH concentration in neuronal cells in vivo, and the underlying mechanisms of how the neuronal cells manging to maintain intracellular GSH homeostasis need to be further clarified. A second potential mechanism is that the Gclc subunit itself may be playing a key role in preventing neuronal cell degeneration. The significant drop of GSH levels in CNS of Gclm KO mouse without clear neuronal cell degeneration supports this speculation. In contrast, Gclc gene polymorphisms have been associated with various types of disease, including cardiovascular disease (24) , cystic fibrosis (43), pulmonary disease (44), type I diabetes (27) , liver disease (45), myoclonic epilepsy (46) and ischemic stroke (25) . Clearly, more work is needed to decipher the actual mechanisms of the discrepancy between these two KO mouse models, i.e. whether other regulatory genes are involved.
Numerous studies have pointed to the critical role of mitochondrial function in neurodegeneration and neurodegenerative diseases. Our data indicate at least that impaired Gclc enzymatic activity is interfering with mitochondrial GSH concentration and GSH/GSSG homeostasis. Most importantly, all our Gclc KO mouse models demonstrate mitochondrial dysfunction. Although whether decreased mitochondrial GSH levels are the trigger of mitochondrial defect is up to further clarification. Nevertheless, from a redox balance perspective, the antioxidant defense is sophisticated and adaptive, and the GSH is the central constituent of this system (47) . Nowhere is its presence more important than in mitochondria. To maintain an adequate concentration of GSH within the mitochondrial matrix is essential for regulation and proper functions of numerous critical processes. Many of the neurodegenerative diseases are part of age-related disease, and reduced Gclc activity has been reported in both CNS and other tissues (48, 49) . This declined activity could therefore be responsible for mitochondrial dysfunction. This may also explain the early onset of gait problems and shortened lifespan of the NEGSKO mouse since the high-energy demand of motor neurons that has to be met by mitochondria makes them more prone to damage. The delayed degeneration in cerebral cortex neurons relative to motor neurons from SLICK mouse study support our speculation.
Intriguingly, striking phenotypes are associated with CNS neuronal cell Gclc deletion. We believe it is due to an intrinsically programmed neuronal cell death via mitochondria and cytochrome C pathways. The functional and morphological neurodegeneration phenotypes from NEGSKO results revealed a striking resemblance to those found in human motor neuron For mitochondrial function analysis, the entire brain was used for mitochondria isolation. Three mice in each group were used, and at least three repeats were performed in each assay. disease, i.e. ALS, demonstrating motor neuron degeneration, muscular atrophy, and denervation. Motor neurons are especially vulnerable to free radical attack and impaired oxidative defense mechanisms may lead to neuronal cell death (50, 51) ; in particular, changes in GSH status due to decreased synthesis or increased degradation. Unfortunately, so far, direct measurements of GSH status in affected neural areas in human ALS patient have not been made mainly due to GSH instability. Shaw et al. (16, 52) and others (53, 54) have done intensive studies searching for GSH receptor in the CNS. However, there is no clear evidence support the existence of GSH receptor, but more likely via a GSH transporter system in the CNS (42) . Nevertheless, increased GSH binding sites in the spinal cord of sALS patients measured by S 35 -GSH are indicative of a decline in GSH levels (55) . Similarly, in forebrain inducible KO (FIGSKO) mice, profound neurodegeneration, particularly in hippocampus, cause brain atrophy and high mortality as well as learning and memory related cognitive impairment. Interestingly, with time, FIGSKO mice demonstrate complete loss of nesting behavior. Rodent nesting behavior is an important indicator of their health status and also a complex interaction between rodents and environment they encounter (56) . Impaired nesting behavior has been reported in various mouse models of neurodegenerative disease, such as AD (57) , PD (58), scrapie and prion disease (59) . Several studies point to the critical role of hippocampus in rodent nesting behavior and believe the hippocampus is controlling spatial memory, orientation and also in recognition of nest-like structures (56) . The severe hippocampal degeneration accompanied with the significant loss of nesting behavior in FIGSKO mice echo and support the key role of hippocampus in nesting related behaviors. In summary, this study describes the novel finding that the Gclc subunit of c-glutamine cysteine synthase is playing a critical role in maintaining intracellular as well as mitochondrial GSH homeostasis. This exciting discovery, together with the common late age onset of many neurodegenerative disorders suggests that chronic oxidative stress is not just the consequence but also the cause of these diseases. Understanding how the Gclc subunit regulates mitochondrial homeostasis is an important goal to pursue in future studies.
Materials and Methods
Animal models
All mouse work was approved by the Institutional Animal Care and Use Committee at Case Western Reserve University. The Gclc conditional knockout mouse (Gclc fl/fl ), in which exon 1 was flanked by two loxP sites was created as described in our previous study (30) . The Gclc floxed mice (C57BL/6) were cross bred with Thy1-cre transgenic mice (FVB background) to produce heterozygous Gclc-Thy1 mice (Gclc
), and were continuously bred with homozygous Gclc flox mice over 8 generations to convert the genomic background close to C57BL/6, and homozygous mice (Gclc ). Gene deletion was achieved via tamoxifen i.p injection in 3 months old mice, 1mg/per mouse, twice per day for five consecutive days.
GSH and GSSG assay
Fresh mouse CNS tissue was quickly dissected and homogenized in freshly made ice-cold 0.1% formic acid. The supernatant was analyzed for GSH and GSSG using the LC/MS method as we have reported in our previous study (60) . A MicroMass Quattro Ultima coupled to an Alliance 2695 Separations Module (Waters Corp., Milford, MA) equipped with a Discovery HS reversed phase C18 column (Supelco Analytics, Bellefonte, PA) was used for LC-MS/MS analysis. Concentration of compounds in samples was quantitated using external calibration of standards. In measurements of endogenous glutathione content, GSH-(glycine-13C2,15N) was used as an internal standard. Commercially available GSH (G6529, Sigma, St. Louis) and GSSG (49740, Sigma, St. Louis) were used for standard curve calibration. For mitochondria, isolated fresh mitochondria were quickly homogenized, and GSH, GSSG were determined following the same procedure.
Immunohistochemistry, immunofluorescence and immunocytochemistry
Mice were deeply anesthetized and perfused with 0.1M phosphate buffer saline (PBS) for 10min, followed by 4% paraformaldehyde (PFA) in 0.1 M PBS for 10min. Mouse brain and spinal cord were post fixed for 18 h before the paraffin embedding process. Negative control without primary antibody was included simultaneously. For immunocytochemistry, cells were fixed using 4% paraformaldehyde. Antigen retrieval was performed in a 0.1M citrate buffer (pH6.0) by microwave at medium power for 5min. Slices/cells were blocked and permeabilized with 5% normal goat serum, 0.3% Triton X-100, and incubated overnight with 0.3% Triton X-100/1% bovine serum albumin (BSA)in PBS containing primary antibodies: ChAT (1:1000), cleaved caspase 3 (1:250) (Cell Signalling, Danvers, MA). Secondary antibodies were labeled with Alexa-Fluor 594, and 488 antibodies (1:1500) (Molecular Probes), and neuronal nuclei with DAPI (Invitrogen). For immunohistochemistry, tissues were immuno-stained, followed with the avidin biotin complex (ABC) method. Images were acquired using a confocal microscope (LSM510-META, Zeiss) at identical settings at the highest intensity for each of the conditions. Images were quantified using LSM Image Browser. For SLICK-A mice, deeply anesthetized mice were perfused with PBS and post fixed with 4% paraformaldehyde for 18 h, and 100 mm section was obtained by Vibratome (Leica). The YFP fluorescence was visualized without stain, and Z-scan was performed 50 mm deep into the tissue. For NMJs stain, 100 mm thick section (vibratome, Leica) was stained with Alexa-488 labeled a-bungarotoxin, neurofilament (2H3, DSHB, University of Iowa) and synaptophysin (Sp11, Thermo Fisher) antibodies, and assembled from z-scan of confocal microscope. For each experimental condition, a group of cells (>40) of each section were analyzed, and the mean signal intensity was measured.
Optical fractionator-based stereological cell counting
The cell counts based on histological procedure stained by either Nissl or ChAT following previous reports (61, 62) . In brief, the adjacent series of sections cut from L3 to L5 form spinal cord and left to right hemisphere for CA1 region of the hippocampus were processed. Optical fractionator was processed on a Leica DM5000B microscope (Leica Microsystem, Bannockburn, IL). The Stereo Investigator software (Microbrightfield, Williston, VT) was used to analyze the cell counts. For each tissue, a pilot study was performed to optimize to determine the stereological parameters. A 20 Â 20 lm probe area and 8 lm depth frame was used for cell counts in this study. The Gunderson coefficients error for m equal 1 was below 0.1. Five mice were used in each group to calculate the average of the cell counts.
Immunoblotting
Mouse brain and spinal cord tissue were homogenized in lysis buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM Na 2 EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM beta-glycerophosphate, 1 mM Na 3 VO 4 and 1 mg/ml leupeptin on ice, and sonicated briefly (5 s). The homogenate was centrifuged at 135,000g for 30min, and the supernatant was collected and the protein concentration was determined using the BCA assay (Thermo Fisher Scientific, Rockford, IL). All buffers were substituted with protease inhibitors (Complete mini; Roche, Branford, CT) before use. Extracted proteins were separated by electrophoresis through 4-20% Bis-Tris gradient polyacrylamide gels containing SDS (0.1%). Proteins were transferred to a PVDF membrane (Millipore), and cytochrome c was detected by the rabbit cytochrome c polyclonal antibody (1:4000) (Cell Signaling, Danvers, MA), and mitochondrialloading control was determined using the rabbit VADC1 polyclonal antibody (1:5000) (Epitomics, Burlingame, CA). Cleaved caspase-3 was detected using the rabbit monoclonal antibody (1:1000) (Cell Signaling, Danvers, MA) and total caspase 3 was detected by pro-caspase antibody (Thermo Fisher Scientific). Detection was performed using HRPconjugated secondary antibodies and the ECL Plus Chemiluminescent Detection System (GE Healthcare, Waukesha, WI). Data were normalized to GAPDH (1:10,000) (Cell Signalling, Danvers, MA).
Mitochondrial assay
Mice were sacrificed by cervical dislocation, and the brain was quickly removed and placed in an isolation buffer (200 mM manitol, 70 mM sucrose, 5 mM MOPS, 0.2 mM EDTA, pH 7.4). Brain mitochondria were isolated using a method described by Stahl et al. (63) with some modifications. The tissue was minced in the isolation buffer and treated with the protease subtilisin A (5 mg/g wet tissue) for 30 s; the protease activity was stopped by dilution with isolation buffer þ bovine serum albumin (BSA, 0.2%), the tissue homogenized, and mitochondria isolated by differential centrifugation. We evaluated the integrated mitochondrial function when substrate oxidation is coupled with phosphorylation of ADP to ATP (oxidative phosphorylation, OXPHOS). OXPHOS was performed with substrates that use different mitochondrial transport systems and dehydrogenases, the tricarboxylic acid cycle, and that donate electrons to specific sites in the electron transport chain (ETC). Oxygen consumption was measured with a Clark-type electrode in respiration buffer (100 mM KCl, 50 mM Mops, 1 mM EGTA, 5 mM KH 2 PO 4 , and 1 mg/ ml defatted BSA, pH 7.4) (64) at 30˚C with glutamate (20 mM) plus malate (5 mM), pyruvate (10 mM) plus malate, succinate (20 mM) plus rotenone (3.75 lM), durohydroquinone (DHQ,1 mM) plus rotenone, and N,N,N',N'-tetramethyl-p-phenylenediamine (TMPD) plus ascorbate (1:10 mM) plus rotenone as substrates. (65) is an index of the efficiency of oxidative phosphorylation. ETC enzyme activities were measured spectrophotometrically as specific donoracceptor oxidoreductase activities in 0.1M phosphate buffer. Both donor and acceptors span specific regions of the ETC (66) . NADH coenzyme Q reductase was measured as the rotenonesensitive oxidation of NADH with decylubiquinone as acceptor, and assesses complex I. Complex II activity was measured as the thenoyltrifluoroacetone (TTFA)-sensitive reduction of 2,6-dicholorophenolindophenol with succinate as substrate and with duroquinone added as a source of exogenous coenzyme Q. Succinate dehydrogenase measures the first two subunits of complex II. Decylubiquinol-cytochrome c oxidoreductase was measured as the antimycin A-sensitive reductase to assess complex III. Cytochrome c oxidase (COX) was measured as the oxidation of reduced cytochrome c and expressed as the first order rate constant. The activity of citrate synthase was measured using a diode array spectrophotometer at 412 nm (67) .
Determination of the mitochondrial membrane potential wm
The membrane potential of the inner mitochondrial membrane was measured using Rhodamine 123 dye following previous report (68) . The mice were sacrificed by decapitation, and the brain cerebral cortex was quickly removed and minced in the suspension buffer (138 mM NaCl, 5.4 mM KCl, 0.17 mM Na 2 HPO 4 , 0.22 mM K 2 PO 4 , 5.5 mM glucose, and 58.4 mM sucrose, pH 7.35), and the cells dissociation was further achieved by trituration through 18 and 21 gauge needles. The resulted suspension was then filtered through 100 lm cell strainer (BD Bioscience, San Jose, CA), and the cells in filtrate were collected after 5min centrifugation at 400 g at 4 C after washing with wash buffer (110 mM NaCl, 5.3 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , 25 mM glucose, 70 mM sucrose, 20 mM HEPES, pH 7.4). The cells were then suspended in Dulbecco's modified Eagle's medium, which was pre-adapted in 5% CO 2 tissue culture incubator for 30min. For the mitochondrial membrane potential assay, 250 mu;l of cell suspension (1Â10 7 cells/ml) was incubated with 0.4 lM Rhodamine 123 in 48-well plate for 15min at 37 C in 5% CO 2 incubator. The fluorescence was recorded at kex490nm/em535nm using a Tecan plate reader (Tecan, Switzerland) after washing three times with Hank's balanced salt solution (ThermoFisher, Grand Island, NY).
Tunnel assay
In situ Cell Death Detection Kit, Fluorescein (Roche) was used to stain the tissue section according to the manufacturer's instructions. After TUNEL labeling, the section was further stained with NueN (Millipore, Billerica, MA), visualized with secondary antibody labeled with Alexa-594 (Molecule Probe). Images were taken using a Zeiss LSM 515 META confocal microscope. Five total slices from the cortex and spinal cord of three mice were imaged per group. Five images were taken per slice. The area of staining was measured for each field.
Electromyography
Animals were anesthetized with Ketamine/Xylazine/ Acepromazine cocktail, and placed on a thermal pad at 37 C for the EMG recording. EMG recordings using a Viking Quest portable EMG machine (Nicolet) were obtained using a 27-gauge, Teflon-coated, monopolar needle electrode with a 70 Â 500 mm recording surface (PRO-37SAF; Electrode Store). A 29-gauge reference needle electrode (GRD-SAF; Electrode Store) was inserted s.c. in close approximation to the recording electrode. A subdermal ground electrode was placed on the back. The recording electrode was inserted into the tibialis anterior (TA) or gastrocnemius/soleus muscles and spontaneous electrical activity was recorded for 2 min.
Behavioral analyses
Mice were moved to the behavior-testing center 2weeks ahead of time, and into the testing room in their home cages at least 2 h before testing. In each experiment, the mice were subjected to behavioral testing at a consistent time of day.
Passive-avoidance fear conditioning A Gemini passive-avoidance system was used. On the training day, the inter-chamber door was closed, and the mouse was placed into a compartment without lights. After a 5s, the chamber lights came on only in the compartment with the mouse, and the inter-chamber door was simultaneously opened. The latency to cross to the dark compartment was recorded. Upon crossing, the inter-chamber door closed, and the mouse received a 2s of 0.3-mA scrambled foot shock, then 30s later, the mouse was placed back to their home cages. Twenty-four hours later, the mouse was placed into the same initial compartment for 5s; the light was turned on, and the inter-chamber door opened. Time to cross to the dark compartment was recorded, but no foot shock was delivered.
T-maze test
The mouse T-maze has three arms of equal dimension ( 
Statistical analysis
All values were expressed as means 6 SD. The statistical significance of differences in mean values was assessed by repeatedmeasures ANOVA or Student's t-test. Only P values <0.05 were considered statistically significant.
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